{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:37:37Z","timestamp":1787312257050,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]},{"name":"the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]},{"name":"the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]},{"name":"the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]},{"name":"the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]},{"name":"Peking University People's Hospital Research and Development Funds","award":["RDC 2015-21"],"award-info":[{"award-number":["RDC 2015-21"]}]},{"name":"Peking University People's Hospital Research and Development Funds","award":["RDC 2015-21"],"award-info":[{"award-number":["RDC 2015-21"]}]},{"name":"National Natural Science Foundation-Beijing Hospitals Authority Youth","award":["No. QML20190303"],"award-info":[{"award-number":["No. QML20190303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although several clinical studies have analysed the relationship between the levels of vascular endothelial growth factor (VEGF) and apelin-13 in venous blood and retinopathy of prematurity (ROP), no definitive conclusions have been reached. This study aimed to investigate the relationship between apelin-13 levels and VEGF levels and ROP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differences in plasma apelin-13 and VEGF levels were analysed in two groups of infants born with birth weight\u2009&lt;\u20091500\u00a0g and gestational age\u2009&lt;\u200932\u00a0weeks at Peking University People\u2019 s Hospital. One group comprised infants diagnosed with ROP and the other group was a control group comprising infants without ROP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Apelin-13 levels were significantly lower in the ROP group than in the control group, while VEGF levels showed the opposite result (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Infants with severe ROP had lower apelin-13 levels and higher VEGF levels than with mild ROP (both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).The receiver operating characteristic curve for apelin-13 level as the indicator of ROP showed that a cut-off value of 119.6\u00a0pg\/mL yielded a sensitivity of 84.8% and a specificity of 63.6%, while for VEGF level, the cut-off value of 84.3\u00a0pg\/mL exhibited a sensitivity of 84.8% and a specificity of 66.7%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma apelin-13 and VEGF levels at 4\u20136\u00a0weeks of age may play a role in assisting the diagnosis of ROP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-022-02565-x","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T13:14:50Z","timestamp":1660223690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case\u2013control study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yimin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaomei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2565_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamaophthalmol.2014.84","volume":"132","author":"A Sommer","year":"2014","unstructured":"Sommer A, Taylor HR, Ravilla TD, West S, Lietman TM, Keenan JD, et al. Challenges of ophthalmic care in the developing world. JAMA Ophthalmol. 2014;132:640\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"2565_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2217\/bmm.12.82","volume":"6","author":"F Cekmez","year":"2012","unstructured":"Cekmez F, Pirgon O, Aydemir G, Dundar B, Cekmez Y, Karaoglu A, et al. Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity. Biomark Med. 2012;6:821\u20135.","journal-title":"Biomark Med"},{"key":"2565_CR3","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1111\/aos.13297","volume":"95","author":"J Feng","year":"2017","unstructured":"Feng J, Zhou Y, Zhang X, Jiang Y. Vascular endothelial growth factor and apelin in plasma of patients with retinopathy of prematurity. Acta Ophthalmol. 2017;95:e514\u20135.","journal-title":"Acta Ophthalmol"},{"key":"2565_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/pr.2015.181","volume":"79","author":"G Hellgren","year":"2016","unstructured":"Hellgren G, L\u00f6fqvist C, H\u00e5rd AL, Hansen-Pupp I, Gram M, Ley D, et al. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity. Pediatr Res. 2016;79:70\u20135.","journal-title":"Pediatr Res"},{"key":"2565_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.biopha.2016.09.048","volume":"84","author":"TP Kalantaripour","year":"2016","unstructured":"Kalantaripour TP, Esmaeili-Mahani S, Sheibani V, Asadi-Shekaari M, Pasban-Aliabadi H. Anticonvulsant and neuroprotective effects of apelin-13 on pentylenetetrazole-induced seizures in male rats. Biomed Pharmacol. 2016;84:258\u201363.","journal-title":"Biomed Pharmacol"},{"key":"2565_CR6","doi-asserted-by":"publisher","first-page":"e69703","DOI":"10.1371\/journal.pone.0069703","volume":"8","author":"Q Lu","year":"2013","unstructured":"Lu Q, Feng J, Jiang YR. The role of apelin in the retina of diabetic rats. PLoS ONE. 2013;8:e69703.","journal-title":"PLoS ONE"},{"key":"2565_CR7","doi-asserted-by":"publisher","first-page":"15062","DOI":"10.1038\/s41598-017-15602-3","volume":"7","author":"Y Ishimaru","year":"2017","unstructured":"Ishimaru Y, Shibagaki F, Yamamuro A, Yoshioka Y, Maeda S. An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice. Sci Rep. 2017;7:15062.","journal-title":"Sci Rep"},{"key":"2565_CR8","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1002\/jcb.26473","volume":"119","author":"W Zhang","year":"2018","unstructured":"Zhang W, Zhang DG, Liang X, Zhang WL, Ma JX. Effects of apelin on retinal microglial cells in a rat model of oxygen-induced retinopathy of prematurity. J Cell Biochem. 2018;119:2900\u201310.","journal-title":"J Cell Biochem"},{"key":"2565_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/OPTH.S127943","volume":"11","author":"YF Ali","year":"2017","unstructured":"Ali YF, El-Morshedy S, Imam AA, Abdelrahman NI, Elsayed RM, Alkholy UM, et al. The role of serum apelin in retinopathy of prematurity. Clin Ophthalmol. 2017;11:387\u201392.","journal-title":"Clin Ophthalmol"},{"key":"2565_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.yexmp.2017.01.015","volume":"102","author":"J Hou","year":"2017","unstructured":"Hou J, Zhong T, Guo T, Miao C, Zhou C, Long H, et al. Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor. Exp Mol Pathol. 2017;102:203\u20139.","journal-title":"Exp Mol Pathol"},{"key":"2565_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/eye.2008.128","volume":"23","author":"AR Wilkinson","year":"2009","unstructured":"Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Eye (Lond). 2009;23:2137\u20139.","journal-title":"Eye (Lond)"},{"key":"2565_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","journal-title":"Arch Ophthalmol"},{"key":"2565_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mce.2012.07.002","volume":"362","author":"A Than","year":"2012","unstructured":"Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ, et al. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol. 2012;362:227\u201341.","journal-title":"Mol Cell Endocrinol"},{"key":"2565_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1373\/clinchem.2016.254649","volume":"63","author":"JPA Ioannidis","year":"2017","unstructured":"Ioannidis JPA, Bossuyt PMM. Waste, Leaks, and Failures in the Biomarker Pipeline. Clin Chem. 2017;63:963\u201372.","journal-title":"Clin Chem"},{"key":"2565_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000444901","volume":"109","author":"R Cayabyab","year":"2016","unstructured":"Cayabyab R, Ramanathan R. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology. Neonatology. 2016;109:369\u201376.","journal-title":"Neonatology"},{"key":"2565_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2014.07.050","volume":"122","author":"ME Hartnett","year":"2015","unstructured":"Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology. 2015;122:200\u201310.","journal-title":"Ophthalmology"},{"key":"2565_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1091-8531(97)90008-2","volume":"1","author":"TL Young","year":"1997","unstructured":"Young TL, Anthony DC, Pierce E, Foley E, Smith LE. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS. 1997;1:105\u201310.","journal-title":"J AAPOS"},{"key":"2565_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.earlhumdev.2007.11.008","volume":"84","author":"BW Fleck","year":"2008","unstructured":"Fleck BW, McIntosh N. Pathogenesis of retinopathy of prematurity and possible preventive strategies. Early Hum Dev. 2008;84:83\u20138.","journal-title":"Early Hum Dev"},{"key":"2565_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","volume":"325","author":"A Kasai","year":"2004","unstructured":"Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun. 2004;325:395\u2013400.","journal-title":"Biochem Biophys Res Commun"},{"key":"2565_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4321\/S0365-66912006001100005","volume":"81","author":"E Villegas-Becerril","year":"2006","unstructured":"Villegas-Becerril E, Gonz\u00e1lez-Fern\u00e1ndez R, Perula-Torres L. Gallardo-Galera JM [IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)]. Arch Soc Esp Oftalmol. 2006;81:641\u20136.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2565_CR21","doi-asserted-by":"publisher","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","volume":"142","author":"WM Fierson","year":"2018","unstructured":"Fierson WM. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics. 2018;142:e20183061.","journal-title":"Pediatrics"},{"key":"2565_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","volume":"63","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618\u201337.","journal-title":"Surv Ophthalmol"},{"key":"2565_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/bjo.2007.128371","volume":"92","author":"C Pieh","year":"2008","unstructured":"Pieh C, Agostini H, Buschbeck C, Kr\u00fcger M, Schulte-M\u00f6nting J, Zirrgiebel U, et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol. 2008;92:689\u201393.","journal-title":"Br J Ophthalmol"},{"key":"2565_CR24","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1080\/14767058.2017.1338261","volume":"31","author":"Y Kandasamy","year":"2018","unstructured":"Kandasamy Y, Hartley L, Rudd D, Smith R. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study. J Matern Fetal Neonatal Med. 2018;31:2202\u20138.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2565_CR25","first-page":"251","volume":"65","author":"D Zhu","year":"2015","unstructured":"Zhu D, Chen C, Shi W. Variations of Vascular Endothelial Growth Factor and Pigment Epithelial-derived Factor Are Related to Retinopathy of Prematurity in Human Babies. West Indian Med J. 2015;65:251\u20135.","journal-title":"West Indian Med J"},{"key":"2565_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.npep.2016.08.006","volume":"60","author":"C Huang","year":"2016","unstructured":"Huang C, Dai C, Gong K, Zuo H, Chu H. Apelin-13 protects neurovascular unit against ischemic injuries through the effects of vascular endothelial growth factor. Neuropeptides. 2016;60:67\u201374.","journal-title":"Neuropeptides"},{"key":"2565_CR27","doi-asserted-by":"publisher","first-page":"e9266","DOI":"10.15252\/emmm.201809266","volume":"11","author":"I Uribesalgo","year":"2019","unstructured":"Uribesalgo I, Hoffmann D, Zhang Y, Kavirayani A, Lazovic J, Berta J, et al. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy. EMBO Mol Med. 2019;11:e9266.","journal-title":"EMBO Mol Med"},{"key":"2565_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/IAE.0b013e31826d3a76","volume":"33","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Jiang YR, Lu Q, Yin H, Tao Y. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab. Retina. 2013;33:613\u201320.","journal-title":"Retina"},{"key":"2565_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","volume":"27","author":"H Kidoya","year":"2008","unstructured":"Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, et al. Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J. 2008;27:522\u201334.","journal-title":"EMBO J"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02565-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02565-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T13:16:45Z","timestamp":1660223805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02565-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2565"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02565-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"20 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the medical ethics committee of the Peking University People\u2019s Hospital (2015PHB108-01) and performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from the study patient\u2019s guardians after the research purpose was explained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}